Sato Y, Maekawa S, Ishii R, Sanada M, Morikawa T, Shiraishi Y, Yoshida K, Nagata Y, Sato-Otsubo A, Yoshizato T, Suzuki H, Shiozawa Y, Kataoka K, Kon A, Aoki K, Chiba K, Tanaka H, Kume H, Miyano S, Fukayama M, Nureki O, Homma Y, Ogawa S

Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome.

Science 344:917-20 (2014)
DOI:10.1126/science.1252328

Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L

GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Nature 340:692-6 (1989)
DOI:10.1038/340692a0

Fukuoka H, Takahashi Y

The role of genetic and epigenetic changes in pituitary tumorigenesis.

Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3

Melmed S

Pathogenesis of pituitary tumors.

Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40

Lacroix A, Feelders RA, Stratakis CA, Nieman LK

Cushing's syndrome.

Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1

Duan K, Gomez Hernandez K, Mete O

Clinicopathological correlates of adrenal Cushing's syndrome.

J Clin Pathol 68:175-86 (2015)
DOI:10.1136/jclinpath-2014-202612

Melmed S

Acromegaly pathogenesis and treatment.

J Clin Invest 119:3189-202 (2009)
DOI:10.1172/JCI39375

Vallar L, Spada A, Giannattasio G

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas.

Nature 330:566-8 (1987)
DOI:10.1038/330566a0